https://medicaldialogues.in/news/industry/pharma/revise-phase-iii-ct-protocol-of-recombinant-rabies-g-protein-vaccine-to-add-safety-cdsco-panel-tells-cadila-103461
0
0
12/4/22 at 8:14am
Organization
Medical Dialogues
Author
Medical Dialogues Team
45 words
0
Comments
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended the vaccine maker Cadila Pharmaceuticals that Phase III...
You are the first to view
Create an account
or login to join the discussion